IDX vs NAN

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IDX

INTEG DIAG FPO [IDX]

52MEDIUM

NAN

NANOSONICS FPO [NAN]

52MEDIUM

Score Breakdown

IDX NAN
Technical
40
49
Catalyst
58
53
Sentiment
50
50
Fundamental
100
94
Momentum
43
41
Risk Gate
34
40

Key Metrics

IDX Metric NAN
$776.0MMarket Cap$965.5M
872KAvg Volume (20d)440K
+1.4%Short Interest+6.9%
$3.07052-Week High$4.770
$1.90552-Week Low$2.960
-0.5%Daily Change-0.3%
$2.070Entry Price$3.220
+2.1%ROE+10.1%
+1.8%Profit Margin+9.9%

Active Signals

IDX Signals

●Stochastic turning bearish from a high level — caution
●Knocking on the door of resistance — if it punches through, things could get interesting
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.0x)
●Strong revenue growth (+56%)
●EPS estimates revised upward (+10pts)

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

Ask Scout AI to compare IDX and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IDX Full Analysis → NAN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).